Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NGRN pseudogene 1 (NGRNP1) is a human pseudogene, meaning it is a non-coding genomic element derived from the duplication or retrotransposition of a parental protein-coding gene. Unlike its parental gene (if identified), NGRNP1 does not produce a functional protein. Pseudogenes in general can participate in genome regulation by acting as decoys for microRNAs, generating regulatory RNAs such as lncRNAs, or affecting gene expression via antisense mechanisms, but for the majority of pseudogenes—including NGRNP1—these regulatory roles are speculative and largely undocumented[1][2][3][4]. Pseudogenes are not considered bona fide therapeutic targets. If you need structured data or mappings for a database, NGRNP1 would map as a pseudogene and should not be listed as a druggable or actionable target. If encountered in a target selection context, it should be flagged as non-target and likely incorrect for most pharmaceutical or mechanistic studies[1][2][3][4].
None established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NGRN pseudogene 1 (NGRNP1).